Annexon, Inc. (ANNX) Insider Trading Disclosures
Annexon, Inc. (ANNX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ANNX
CIK: 1528115
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerOanh Nguyen
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-25 | 2026-09-24 | 4 Filing | 0001818520-26-000003 | View SEC Doc Filr Page |
| 144 | 2026-08-13 | — | 144 Filing | 0001959173-26-005993 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0001614869-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-08-12 | 2026-08-10 | 3 Filing | 0001614869-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-346779 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345672 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342524 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0000093751-26-000411 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-336867 | View SEC Doc Filr Page |
| 8-K | 2026-07-30 | 2026-07-30 | 8-K | 0001193125-26-326199 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-002180 | View SEC Doc Filr Page |
| 144 | 2026-07-15 | — | 144 Filing | 0001959173-26-005238 | View SEC Doc Filr Page |
| 144 | 2026-07-14 | — | 144 Filing | 0001959173-26-005219 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001104659-26-082022 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0000315066-26-001457 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001553338-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001315797-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001373097-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001900452-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001650126-26-000001 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001824280-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | 4 Filing | 0001818525-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | 8-K | 0001193125-26-269479 | View SEC Doc Filr Page |
| 4 | 2026-05-29 | 2026-05-28 | 4 Filing | 0001315797-26-000001 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000921895-26-001383 | View SEC Doc Filr Page |